Correction: A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide

13 de May de 2025 by inmunoadmin

Spread the love

J Immunol. 2025 May 12:vkaf113. doi: 10.1093/jimmun/vkaf113. Online ahead of print.

NO ABSTRACT

PMID:40356078 | DOI:10.1093/jimmun/vkaf113

301 Moved Permanently